Activation of PPARγ by 12/15-lipoxygenase during cerebral ischemia-reperfusion injury

International Journal of Molecular Medicine

Volumn 35, Issue 1, 2015, Pages 195-201

  Han, Jing ^a   Sun, Li ^b   Xu, Yanwei ^a   Liang, Hao ^b   Cheng, Yan ^a  

^a Tianjin Neurological Institute   (China)

^b TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

12 hydroxyeicosatetraenoic acid; Oxygen glucose deprivation; Peroxisome proliferator responsive element; Peroxisome proliferator activated receptor

Indexed keywords

12 HYDROXYICOSATETRAENOIC ACID; ACYL COENZYME A OXIDASE; ANTISENSE OLIGONUCLEOTIDE; ARACHIDONATE 12 LIPOXYGENASE; ARACHIDONATE 15 LIPOXYGENASE; INDUCIBLE NITRIC OXIDE SYNTHASE; LIPOPROTEIN LIPASE; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; 12-15-LIPOXYGENASE; GLUCOSE; OXYGEN; PROTEIN BINDING;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CELL; BRAIN CELL CULTURE; BRAIN ISCHEMIA; BRAIN TISSUE; CELL SURVIVAL; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; GENE TARGETING; IMMUNOFLUORESCENCE; INVESTIGATIVE PROCEDURES; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; NEUROPROTECTION; NONHUMAN; OXYGEN GLUCOSE DEPRIVATION; PROTEIN DNA BINDING; PROTEIN EXPRESSION; RAT; REPERFUSION INJURY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; SURVIVAL RATE; UPREGULATION; WESTERN BLOTTING; ANIMAL; BRAIN CORTEX; CEREBRAL ARTERY DISEASE; COMPLICATION; DISEASE MODEL; DRUG EFFECTS; ENZYME ACTIVATION; GENETICS; METABOLISM; NERVE CELL; PATHOLOGY; PROTEIN TRANSPORT; VASCULARIZATION;

ANIMALS; ARACHIDONATE 12-LIPOXYGENASE; ARACHIDONATE 15-LIPOXYGENASE; CEREBRAL CORTEX; DISEASE MODELS, ANIMAL; ENZYME ACTIVATION; GENE EXPRESSION; GLUCOSE; INFARCTION, MIDDLE CEREBRAL ARTERY; MALE; NEURONS; NITRIC OXIDE SYNTHASE TYPE II; OXYGEN; PPAR GAMMA; PROTEIN BINDING; PROTEIN TRANSPORT; RATS; REPERFUSION INJURY;

EID: 84917690827     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2014.1998     Document Type: Article

References (28)

1. Boyle PJ: Diabetes mellitus and macrovascular disease: mechanisms and mediators. Am J Med 120 (9 Suppl): S12-S17, 2007.
2. Xu YW, Sun L, Liang H, Sun GM and Cheng Y: 12/15-lipoxygenase inhibitor baicalein suppresses PPAR gamma expression and nuclear translocation induced by cerebral ischemia/reperfusion. Brain Res 1307: 149-157, 2010.
3. Collino M, Aragno M, Mastrocola R, et al: Modulation of the oxidative stress and inflammatory response by PPAR-gamma agonists in the hippocampus of rats exposed to cerebral ischemia/reperfusion. Eur J Pharmacol 530: 70-80, 2006.
4. Zhao Y, Patzer A, Herdegen T, Gohlke P and Culman J: Activation of cerebral peroxisome proliferator-activated receptors gamma promotes neuroprotection by attenuation of neuronal cyclooxygenase-2 overexpression after focal cerebral ischemia in rats. FASEB J 20: 1162-1175, 2006.
5. Li Q, Cheon YP, Kannan A, Shanker S, Bagchi IC and Bagchi MK: A novel pathway involving progesterone receptor, 12/15-lipoxygenase-derived eicosanoids and peroxisome proliferator-activated receptor gamma regulates implantation in mice. J Biol Chem 279: 11570-11581, 2004.
6. Lebeau A, Terro F, Rostene W and Pelaprat D: Blockade of 12-lipoxygenase expression protects cortical neurons from apoptosis induced by beta-amyloid peptide. Cell Death Differ 11: 875-884, 2004.
7. Ou Z, Zhao X, Labiche LA, et al: Neuronal expression of peroxisome proliferator-activated receptor-gamma (PPARgamma) and 15d-prostaglandin J2-mediated protection of brain after experimental cerebral ischemia in rat. Brain Res 1096: 196-203, 2006.
8. Sundararajan S, Gamboa JL, Victor NA, Wanderi EW, Lust WD and Landreth GE: Peroxisome proliferator-activated receptor-gamma ligands reduce inflammation and infarction size in transient focal ischemia. Neuroscience 130: 685-696, 2005.
9. Pereira MP, Hurtado O, Cárdenas A, et al: Rosiglitazone and 15-deoxy-delta12, 14-prostaglandin J2 cause potent neuroprotection after experimental stroke through noncompletely overlapping mechanisms. J Cereb Blood Flow Metab 26: 218-229, 2006.
10. Chu K, Lee ST, Koo JS, et al: Peroxisome proliferator-activated receptor-gamma-agonist, rosiglitazone, promotes angiogenesis after focal cerebral ischemia. Brain Res 1093: 208-218, 2006.
11. Tureyen K, Kapadia R, Bowen KK, et al: Peroxisome proliferator-activated receptor-gamma agonists induce neuroprotection following transient focal ischemia in normotensive, normoglycemic as well as hypertensive and type-2 diabetic rodents. J Neurochem 101: 41-56, 2007.
12. Zhao X, Strong R, Zhang J, et al: Neuronal PPARgamma deficiency increases susceptibility to brain damage after cerebral ischemia. J Neurosci 29: 6186-6195, 2009.
13. Czapski GA, Czubowicz K and Strosznajder RP: Evaluation of the antioxidative properties of lipoxygenase inhibitors. Pharmacol Rep 64: 1179-1188, 2012.
14. Giannopoulos PF, Joshi YB, Chu J and Praticò D: The 12-15-lipoxygenase is a modulator of Alzheimer's-related tau pathology in vivo. Aging Cell 12: 1082-1090, 2013.
15. Praticò D, Zhukareva V, Yao Y, et al: 12/15-lipoxygenase is increased in Alzheimer's disease: possible involvement in brain oxidative stress. Am J Pathol 164: 1655-1662, 2004.
16. Limor R, Sharon O, Knoll E, Many A, Weisinger G and Stern N: Lipoxygenase-derived metabolites are regulators of peroxisome proliferator-activated receptor gamma-2 expression in human vascular smooth muscle cells. Am J Hypertens 21: 219-223, 2008.
17. Bull AW, Steffensen KR, Leers J and Rafter JJ: Activation of PPAR gamma in colon tumor cell lines by oxidized metabolites of linoleic acid, endogenous ligands for PPAR gamma. Carcinogenesis 24: 1717-1722, 2003.
18. Yao Y, Clark CM, Trojanowski JQ, Lee VM and Pratico D: Elevation of 12/15 lipoxygenase products in AD and mild cognitive impairment. Ann Neurol 58: 623-626, 2005.
19. Palluy O, Bendani M, Vallat JM and Rigaud M: 12-lipoxygenase mRNA expression by cultured neurons. C R Acad Sci III 317: 813-818, 1994.
20. Pekcec A, Yigitkanli K, Jung JE, Pallast S, Xing C, Antipenko A, Minchenko M, Nikolov DB, Holman TR, Lo EH and van Leyen K: Following experimental stroke, the recovering brain is vulnerable to lipoxygenase-dependent semaphorin signaling. FASEB J 27: 437-445, 2013.
21. Marcus SL, Miyata KS, Zhang B, Subramani S, Rachubinski RA and Capone JP: Diverse peroxisome proliferator-activated receptors bind to the peroxisome proliferator-responsive elements of the rat hydratase/dehydrogenase and fatty acyl-CoA oxidase genes but differentially induce expression. Proc Natl Acad Sci USA 90: 5723-5727, 1993.
22. Okuno Y, Matsuda M, Miyata Y, et al: Human catalase gene is regulated by peroxisome proliferator activated receptor-gamma through a response element distinct from that of mouse. Endocr J 57: 303-309, 2010.
23. Venkatachalam G, Kumar AP, Yue LS, Pervaiz S, Clement MV and Sakharkar MK: Computational identification and experimental validation of PPRE motifs in NHE1 and MnSOD genes of human. BMC Genomics 10 Suppl 3: S5, 2009.
24. Gresa-Arribas N, Viéitez C, Dentesano G, Serratosa J, Saura J and Solà C: Modelling neuroinflammation in vitro: a tool to test the potential neuroprotective effect of anti-inflammatory agents. PLoS One 7: e45227, 2012.
25. Kapinya KJ, Löwl D, Fütterer C, et al: Tolerance against ischemic neuronal injury can be induced by volatile anesthetics and is inducible no synthase dependent. Stroke 33: 1889-1898, 2002.
26. Choi SH, Lee DY, Kim SU and Jin BK: Thrombin-induced oxidative stress contributes to the death of hippocampal neurons in vivo: role of microglial NADPH oxidase. J Neurosci 25: 4082-4090, 2005.
27. Xing B, Xin T, Hunter RL and Bing G: Pioglitazone inhibition of lipopolysaccharide-induced nitric oxide synthase is associated with altered activity of p38 MAP kinase and PI3K/Akt. J Neuroinflammation 5: 4, 2008.
28. Mulderry PK and Dobson SP: Regulation of VIP and other neuropeptides by c-Jun in sensory neurons: implications for the neuropeptide response to axotomy. Eur J Neurosci 8: 2479-2491, 1996.